Figures & data
Figure 1 Pedigree and sequence analysis of the Chinese family. (A) Pedigree of the Chinese family. The filled circle indicates affected individual, and the open circle and box indicate non-affected individuals. The proband is indicated by an arrow. (B) Sanger sequencing confirmation of the Chinese family. The proband (II-1) carried compound heterozygous mutations: c.1172G>A inherited from his father (I-1) and c.1752C>A from his mother (I-2). Square: Male; Circle: Female.
![Figure 1 Pedigree and sequence analysis of the Chinese family. (A) Pedigree of the Chinese family. The filled circle indicates affected individual, and the open circle and box indicate non-affected individuals. The proband is indicated by an arrow. (B) Sanger sequencing confirmation of the Chinese family. The proband (II-1) carried compound heterozygous mutations: c.1172G>A inherited from his father (I-1) and c.1752C>A from his mother (I-2). Square: Male; Circle: Female.](/cms/asset/bcf1f53f-1623-4193-b925-c2ac63a998de/dpgp_a_12178038_f0001_c.jpg)
Figure 2 Scheme of Twinkle structure (NP_068602) and distribution of pathogenic variants associated with Perrault syndrome. The N-terminal contains the mitochondrial targeting sequence (MTS); then, there is an N-terminal primase domain, a C-terminal helicase domain, and a linker region connecting the two domains. The novel missense variant identified in the proband in this study is in red.
![Figure 2 Scheme of Twinkle structure (NP_068602) and distribution of pathogenic variants associated with Perrault syndrome. The N-terminal contains the mitochondrial targeting sequence (MTS); then, there is an N-terminal primase domain, a C-terminal helicase domain, and a linker region connecting the two domains. The novel missense variant identified in the proband in this study is in red.](/cms/asset/61d24c67-f625-43fa-be41-1d31151a3a14/dpgp_a_12178038_f0002_b.jpg)
Table 1 Common Clinical Features of Patients with TWNK Mutations in PRLTS5
Table 2 Reported TWNK Mutations in PRLTS5